Search

Eric Milledge Phones & Addresses

  • 898 Panama Ct, Marco Island, FL 34145 (239) 394-1859
  • 908 Panama Ct, Marco Island, FL 34145 (239) 394-1859
  • 908 Panama Ct UNIT 607, Marco Island, FL 34145 (239) 394-1859
  • 898 Panama Ct UNIT 3, Marco Island, FL 34145
  • 21995 Scenic Heights Way, Saratoga, CA 95070
  • 1001 Cherry Hill Rd, Princeton, NJ 08540 (609) 466-3698 (609) 466-6988
  • Hopewell, NJ
  • 52 Van Doren Way, Belle Mead, NJ 08502 (908) 874-7906 (908) 874-8880
  • Santa Clara, CA

Business Records

Name / Title
Company / Classification
Phones & Addresses
Eric P. Milledge
Manager
Milledge Investment 1 LLC
908 Panama Ct, Marco Island, FL 34145
Eric Milledge
Vice President Info Management
Ortho-McNeil Pharmaceutical, Inc
Mfg Medicinal/Botanical Products Mfg Pharmaceutical Preparations · Mfg Medicinal/Botanical Products · Mfg Pharmaceutical Preparations
PO Box 300, Raritan, NJ 08869
1000 Us Hwy 202, Raritan, NJ 08869
(908) 218-6000, (908) 218-7701
Eric Milledge
Chairman of the Board
Lifescan Products LLC
Mfg Surgical/Medical Instruments Mfg Electromedical Equipment
1000 Gibraltar Dr, Milpitas, CA 95035
(408) 719-8443
Eric Milledge
Chairman
Johnson & Johnson
In-Vitro Diagnostic Substance Manufacturing
1000 Gibraltar Dr, Milpitas, CA 95035
(408) 263-9789
Eric P Milledge
ERIC MILLEDGE CONSULTING, LLC
Business Consulting Services
908 Panama Ct SUITE 607, Marco Island, FL 34145
Eric Milledge
Chairman
Cequr Corporation
Mfg Medicinals & Botanicals Products
(508) 486-0010
Eric P. Milledge
Chairman, Secretary
Mariners Palm Harbor Condominium Association, Inc
247 N Collier Blvd, Marco Island, FL 34145
PO Box 2056, Marco Island, FL 34146
815 Bald Eagle Dr, Marco Island, FL 34145
PO Box 394, Camp Dodge, IA 50131

Publications

Us Patents

Method For Integrating Facilitated Blood Flow And Blood Analyte Monitoring

View page
US Patent:
20090043177, Feb 12, 2009
Filed:
Aug 8, 2007
Appl. No.:
11/836030
Inventors:
Eric Milledge - Belle Mead NJ, US
Mahyar Z. Kermani - Pleasanton CA, US
International Classification:
A61B 5/145
US Classification:
600309
Abstract:
A method for the integrated facilitization of blood flow and monitoring of blood analyte concentration (for example, blood glucose concentration) includes implanting a stent configured to facilitate blood flow into a cardiovascular system of a user's body with the stent having attached thereto a continuous blood analyte determination module of a blood analyte monitoring system. The method also includes disposing a reader module of the blood analyte monitoring system external to the user's body and in proximity to a portion of the user's skin layer and monitoring blood analyte concentration via (i) emitting an RF carrier signal from the reader module toward the stent; (ii) receiving the RF carrier signal at a reflection antenna of the continuous blood analyte determination module; (iii) reflecting a modulated signal by the reflection antenna with the modulated signal being encoded with a blood analyte concentration determined by a sensor of the continuous blood analyte determination module; (iv) receiving the modulated signal by the reader module; and (v) decoding the analyte concentration from the modulated signal by the reader module.

Integrated Stent And Blood Analyte Monitoring System

View page
US Patent:
20090043183, Feb 12, 2009
Filed:
Aug 8, 2007
Appl. No.:
11/835992
Inventors:
Mahyar Z. KERMANI - Pleasanton CA, US
Eric Milledge - Belle Mead NJ, US
International Classification:
A61B 5/145
A61F 2/06
US Classification:
600365, 623 115
Abstract:
An integrated stent and blood analyte monitoring system includes a stent configured for implantation into a cardiovascular system of a user's body and a blood analyte monitoring system. The blood analyte monitoring system includes a continuous blood analyte determination module attached to the stent and a reader module configured for disposition external to the user's body and proximal to a portion of the user's skin layer. The continuous blood analyte determination module has a sensor for determining the concentration of a blood analyte (e.g., blood glucose concentration) and a reflection antenna with a switch. The reader module is configured to emit an RF carrier signal toward the stent. The reflection antenna is configured to receive the RF carrier signal and reflect a modulated signal that has been modulated by the switch to encode an analyte concentration determined by the sensor. Furthermore, the reader module is configured to receive the modulated signal and decode the analyte concentration therefrom.
Eric Peter Milledge from Marco Island, FL, age ~74 Get Report